0 Комментарии
0 Поделились
206 Просмотры
0 предпросмотр
Спонсоры
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
mRNA Therapeutics Market: Oncology Applications Driving DemandThe pharmaceutical world is currently witnessing a shift as seismic as the discovery of penicillin or the invention of the X-ray. At the heart of this revolution is Messenger RNA (mRNA). While the global population became intimately acquainted with mRNA through COVID-19 vaccines, the scientific community recognizes that this was merely the "proof of concept" phase. Today, the mRNA...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Pet Cancer Therapeutics Market Gains Momentum with Expanding Veterinary Oncology InfrastructureThe global Pet Cancer Therapeutics Market is witnessing substantial growth as pet owners increasingly prioritize advanced healthcare solutions for companion animals. The rising prevalence of cancer among pets, growing awareness regarding veterinary oncology, and advancements in treatment modalities such as immunotherapy, targeted therapy, and chemotherapy are creating significant opportunities...0 Комментарии 0 Поделились 634 Просмотры 0 предпросмотр
-
All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Global Anti-Radiation Drugs Market Trends Driving Future DemandIncreasing collaboration across healthcare, defense, and research sectors is driving innovation in radioprotective therapies. Enhanced emergency response planning supports long-term demand. The market is positioned for consistent growth. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$ XX million in...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Harnessing Innovation and Growth: Breast Cancer Therapeutics Market Developments and Forecast by 2030The Breast Cancer Therapeutics Market is poised for robust expansion as scientific breakthroughs, rising disease prevalence, and enhanced healthcare delivery systems converge to create a fertile environment for growth. According to industry research, the breast cancer therapeutics market size is projected to grow from US$ 31,073.52 million in 2022 to US$ 63,967.05 million by 2030, recording a...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Innovations Driving the Basal Cell Carcinoma Treatment Market ExpansionExpanding clinical trials are driving innovation in basal cell carcinoma therapies.Ongoing research is exploring more effective and less invasive treatments.Scientific progress is strengthening the market’s future outlook. The Basal Cell Carcinoma Treatment Market is expected to register a CAGR of 9.3% from 2025 to 2031, with market size rising from US$ XX million in 2024 to US$ XX...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Next Wave Oncology Innovation: Anti - Neoplastic Agents Market Growth, Trends, and Strategic Insights (2026–2034)The Anti - Neoplastic Agents Market is evolving rapidly as the global healthcare ecosystem intensifies efforts to combat the rising burden of cancer. These agents remain a cornerstone of oncology treatment, playing a critical role in slowing, inhibiting, or eliminating cancer cell growth across multiple cancer types. The increasing incidence of cancer worldwide, combined with advancements in...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Specialty Pharmaceuticals Market 2031: Deep Dive into Dynamics, Opportunities, and Strategic EvolutionThe Specialty Pharmaceuticals Market is emerging as a cornerstone of modern healthcare, driven by the growing need for advanced therapies targeting complex, chronic, and rare diseases. Specialty pharmaceuticals often biologics or high-cost, high-complexity drugs are redefining treatment paradigms by offering improved efficacy, precision, and patient outcomes. As healthcare systems increasingly...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
Расширенные страницы
Спонсоры
Спонсоры
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek